Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension Study of Mirogabalin in Pain Associated with Fibromyalgia
2013-005164-26Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mirogabalin in fibromyalgia (FM), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Long-term safety of mirogabalin (DS-5565). Started Sep 2014; status: completed.
02
Drugs
mirogabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2013-005164-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005164-26.